Want to know what it takes to grow in the Nordic pharma industry over the next 3-5 years? Get the insights from Forward Thinkers Review 2.0

X

About

What if your data could work harder for you?

Your ability to make the right decisions depends on data-driven insights. After all, every decision you make in pharma shapes how swiftly and safely life-changing treatments reach patients. From years before launch through post-market success, we understand the complexities you face and support you with consulting and services.

To that end, we combine exclusive sales data, patient data, real-world evidence, market access, and market research consulting, providing the full-picture understanding you need to stay ahead.

How we can support your success


Why does the right partner make all the difference?

With 50 years of experience in the life science industry, we provide clear insights tailored to your challenges. Our team of 50+ specialists collaborates with you to address complex issues, supporting both patient outcomes and your commercial objectives. Our experts range from anthropologists to health economists and data scientists, ensuring we understand not just the data but its human impact.


As part of the Lif group, the Danish Association of the Pharmaceutical Industry, we are aligned with the industry’s ethical standards, so you can rely on a partner that prioritizes integrity and quality.

DLIMI → Signum

Your success has always guided our evolution. Since our founding 50 years ago and establishment as DLIMI (Dansk Lægemiddel Information Market Intelligence), we’ve provided data services and consulting expertise to Denmark’s pharmaceutical industry. As your needs expanded beyond borders, we grew too.

In 2023, we became Signum – meaning ‘sign’ or ‘bell’ in Latin – reflecting our core purpose of interpreting market signals and data patterns that shape your decisions.

Like ancient wayfarers who looked to signs for direction, we help you read the complex indicators in the life science market, turning our decades of market intelligence into your strategic advantage.

You might know us as DLIMI (Dansk Lægemiddel Information Market Intelligence), our name before 2024.

99.7% coverage of Danish pharma sales

Close industry partnerships

Daily updates across 60,000 product lines

Owned by the Danish Association of the Pharmaceutical Industry (Lif)

20+ data sources for maximum reliability

Unique market insight sharing model

Complete Nordic market coverage

50 years in pharma market intelligence

Academic and regulatory research partnerships

Sign up for our newsletter


Get the latest news, instant insights, cases, whitepapers and stay up to date.

We promise only to send relevant and exciting news.